Krebs Biochemicals & Industries Ltd.
| BSE: 524518 | Sector: Health care |
| NSE: KREBSBIO | ISIN Code: INE268B01013 |
| BSE 00:00 | 28 Sep | 90.95 |
2.95 (3.35%) |
OPEN
87.70 |
HIGH
91.50 |
LOW
87.70 |
| NSE 00:00 | 28 Sep | 91.00 |
4.05 (4.66%) |
OPEN
85.20 |
HIGH
92.10 |
LOW
83.00 |
| OPEN | 87.70 |
| PREVIOUS CLOSE | 88.00 |
| VOLUME | 1327 |
| 52-Week high | 110.90 |
| 52-Week low | 60.10 |
| P/E | |
| Mkt Cap.(Rs cr) | 178 |
| Buy Price | 90.30 |
| Buy Qty | 300.00 |
| Sell Price | 95.00 |
| Sell Qty | 1.00 |
Krebs Biochemicals & Industries Ltd. (KREBSBIO) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 510.20 | 20.75 | 4.24 | 3211.14 |
| Dr Reddy's Labs | 5127.15 | 13.10 | 0.26 | 2937.70 |
| Cipla | 774.65 | 4.45 | 0.58 | 2318.17 |
| Aurobindo Pharma | 801.60 | 29.70 | 3.85 | 1872.74 |
| Cadila Health. | 390.50 | 4.90 | 1.27 | 1412.90 |
| Divi's Lab. | 3092.90 | 31.45 | 1.03 | 1372.71 |
| Glenmark Pharma. | 495.40 | 12.60 | 2.61 | 1354.55 |
| Alkem Lab | 2771.90 | -28.00 | -1.00 | 1264.42 |
| Alembic Pharma | 985.40 | 30.30 | 3.17 | 969.40 |
| Torrent Pharma. | 2692.90 | -26.10 | -0.96 | 938.51 |
| P & G Health Ltd | 5017.55 | 129.90 | 2.66 | 838.72 |
| Lupin | 1007.85 | 10.05 | 1.01 | 727.55 |
| Ipca Labs. | 2077.05 | 7.95 | 0.38 | 652.46 |
| Abbott India | 16321.70 | 115.05 | 0.71 | 592.93 |
| Fortis Health. | 137.10 | -0.15 | -0.11 | 513.33 |
| Pfizer | 5013.70 | 95.40 | 1.94 | 509.13 |
| Natco Pharma | 938.55 | 53.00 | 5.98 | 474.50 |
| Apollo Hospitals | 2060.10 | 29.80 | 1.47 | 470.30 |
| Granules India | 399.80 | 24.05 | 6.40 | 444.07 |
| Ajanta Pharma | 1587.05 | 35.95 | 2.32 | 441.13 |
Quick Links for Krebs Biochemicals & Industries:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
